FTC brings first product-hopping claim in Suboxone settlement
iStock/okskaz
As part of a settlement to resolve criminal and civil liability for its marketing of Suboxone, Reckitt Benckiser has agreed to a Federal Trade Commission order to pay $50 million and change conduct that allegedly blocked generic competition to the opioid addiction treatment.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10